← Leaderboards
Jide Tian
University Of California Los Angeles
$1,678,030
Attributed
$1,678,030
Total exposure
6
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $301.3K · FY2006–07$500K$375K$250K$125K$0
'06
'07
Funding mix
By agency
NIH$1,678,030 · 6
By mechanism
R21$1,204,230 · 4
R29$321,300 · 1
R03$152,500 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of California Los Angeles
Same institution · by research overlap
- Daniel Kaufman$8,790,517
- Peipei Ping$42,474,820
- Hua Linda Cai$18,515,897
- Thomas Martin Vondriska$19,397,244
- Michael A Teitell$22,516,970
Others in their field
Top investigators on “T Lymphocyte”
- Barton F Haynes · Duke University$408,040,925
- Lawrence Corey · Fred Hutchinson Cancer Center$299,247,526
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$157,640,776
- Dan H. Barouch · Fred Hutchinson Cancer Center$139,062,963
- James Dennis Neaton · Northwestern University$107,288,548
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$83,920,398
Research focus
T LymphocyteInsulin Dependent Diabetes MellitusNod MouseApoptosisTissue /Cell CultureAutoimmunityLeukocyte Activation /TransformationCytokineBiological Signal TransductionGene TherapyCalcium FluxDiabetes MellitusGamma AminobutyrateGaba ReceptorReceptor ExpressionSurface AntigensDelayed HypersensitivityNeuroimmunomodulationImmunotherapyPolymerase Chain ReactionAntigen PresentationCell Cell InteractionAutoantigensEnzyme Linked Immunosorbent Assay
Grant awards (13)
PDL1-based rAAV-mediated gene therapy for mouse T1D$150,020
R21 · FY2007 · DK · contact PI
A Derivative of Oleanolic Acid: Anti-Hepatocellular Carcinoma (HCC) Activity$142,519
R21 · FY2007 · CA · contact PI
PDL1-based rAAV-mediated gene therapy for mouse T1D$154,500
R21 · FY2006 · DK · contact PI
A Derivative of Oleanolic Acid: Anti-HCC Activity$146,775
R21 · FY2006 · CA · contact PI
NOD B Cells in Determinant Spreading of T Cell Immunity$76,250
R03 · FY2004 · AI
Genetic Modification of Mouse Islets for Transplantation$152,500
R21 · FY2003 · AI
NOD B Cells in Determinant Spreading of T Cell Immunity$76,250
R03 · FY2003 · AI
Genetic Modification of DCs as Immunotherapy for IDDM$152,500
R21 · FY2002 · DK
Genetic Modification of Mouse Islets for Transplantation$152,500
R21 · FY2002 · AI
LYMPHOCYTIC GABAA RECEPTORS$107,100
R29 · FY2002 · AI
Genetic Modification of DCs as Immunotherapy for IDDM$152,916
R21 · FY2001 · DK
LYMPHOCYTIC GABAA RECEPTORS$107,100
R29 · FY2001 · AI
LYMPHOCYTIC GABAA RECEPTORS$107,100
R29 · FY2000 · AI